20-46034991-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020708.5(SLC12A5):​c.96C>T​(p.Thr32Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00317 in 1,613,968 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 3 hom., cov: 31)
Exomes 𝑓: 0.0033 ( 20 hom. )

Consequence

SLC12A5
NM_020708.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -8.14

Publications

1 publications found
Variant links:
Genes affected
SLC12A5 (HGNC:13818): (solute carrier family 12 member 5) K-Cl cotransporters are proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The protein encoded by this gene is an integral membrane K-Cl cotransporter that can function in either a net efflux or influx pathway, depending on the chemical concentration gradients of potassium and chloride. The encoded protein can act as a homomultimer, or as a heteromultimer with other K-Cl cotransporters, to maintain chloride homeostasis in neurons. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Sep 2008]
SLC12A5 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 34
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • epilepsy of infancy with migrating focal seizures
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 14
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 20-46034991-C-T is Benign according to our data. Variant chr20-46034991-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 542322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.14 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00208 (316/152154) while in subpopulation NFE AF = 0.00363 (247/67982). AF 95% confidence interval is 0.00326. There are 3 homozygotes in GnomAd4. There are 136 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A5NM_020708.5 linkc.96C>T p.Thr32Thr synonymous_variant Exon 2 of 26 ENST00000243964.7 NP_065759.1
SLC12A5NM_001134771.2 linkc.165C>T p.Thr55Thr synonymous_variant Exon 2 of 26 NP_001128243.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A5ENST00000243964.7 linkc.96C>T p.Thr32Thr synonymous_variant Exon 2 of 26 1 NM_020708.5 ENSP00000243964.4

Frequencies

GnomAD3 genomes
AF:
0.00208
AC:
316
AN:
152036
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000604
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00363
Gnomad OTH
AF:
0.000962
GnomAD2 exomes
AF:
0.00251
AC:
630
AN:
251462
AF XY:
0.00261
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.000694
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00203
Gnomad NFE exome
AF:
0.00363
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00328
AC:
4798
AN:
1461814
Hom.:
20
Cov.:
32
AF XY:
0.00320
AC XY:
2328
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.000783
AC:
35
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00111
AC:
29
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00312
AC:
269
AN:
86256
European-Finnish (FIN)
AF:
0.00197
AC:
105
AN:
53416
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5766
European-Non Finnish (NFE)
AF:
0.00376
AC:
4176
AN:
1111960
Other (OTH)
AF:
0.00255
AC:
154
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
279
557
836
1114
1393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00208
AC:
316
AN:
152154
Hom.:
3
Cov.:
31
AF XY:
0.00183
AC XY:
136
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41512
American (AMR)
AF:
0.000523
AC:
8
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4818
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00363
AC:
247
AN:
67982
Other (OTH)
AF:
0.000951
AC:
2
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00308
Hom.:
1
Bravo
AF:
0.00188
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00300
EpiControl
AF:
0.00314

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC12A5: BP4, BP7, BS2 -

May 23, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 34 Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.56
DANN
Benign
0.64
PhyloP100
-8.1
Mutation Taster
=289/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143969641; hg19: chr20-44663630; API